Description
ASP-3026 inhibits anaplastic lymphoma kinase (ALK) and shows anticancer chemotherapeutic activity. Treatment with ASP-3026 lowers tumor burden in lung and intrapleural tumor models.
Product Info
| Cas No. | 1097917-15-1 |
|---|---|
| Purity | ≥99% |
| Formula | C29H40N8O3S |
| Formula Wt. | 580.74 |
| IUPAC Name | 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N- (2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine |
| Synonym | ASP-3026, ASP 3026 |
| Solubility | DMSO 14 mg/mL (24.1 mM) Water Insoluble Ethanol Insoluble |
| Appearance | White Crystal Powder |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
www.clinicaltrials.gov/show/NCT01284192
www.clinicaltrials.gov/show/NCT014001504